Literature DB >> 10968540

Autogenous bone marrow graft to non-ossifying fibroma with a pathologic fracture.

T Hase1, T Miki.   

Abstract

Non-ossifying fibroma with a pathological fracture of the radius in a 10-year-old girl was successfully treated by curettage and autogenous bone marrow graft. The lesion was completely replaced by normal bone at 1 year after the operation. Autogenous bone-marrow graft was considered to be a useful method for the treatment of non-ossifying fibroma with minimal morbidity of the graft-harvesting site.

Entities:  

Mesh：

Year:  2000        PMID： 10968540     DOI： 10.1007/s004029900100

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN： 0936-8051            Impact factor:   3.067


  5 in total

1.  Treatment of intracapsular femoral neck lesions: aggressive or conservative surgery?

Authors:  Hasan Havitçioğlu; Çağdaş Biçen; Onur Hapa; Ali Balcı
Journal:  Musculoskelet Surg       Date:  2012-12-21

2.  Surgical treatment for symptomatic non-ossifying fibromas of the lower extremity with calcium sulfate grafts in skeletally immature patients.

Authors:  Antonio Andreacchio; Flavia Alberghina; Gianluca Testa; Federico Canavese
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-08-17

3.  Curettage and graft alleviates athletic-limiting pain in benign lytic bone lesions.

Authors:  Vincent M Moretti; Rachel L Slotcavage; Eileen A Crawford; Richard D Lackman; Christian M Ogilvie
Journal:  Clin Orthop Relat Res       Date:  2010-05-12       Impact factor: 4.176

Review 4.  Non-ossifying fibroma, fibrous cortical defect and Jaffe-Campanacci syndrome: a biologic and clinical review.

Authors:  Henry J Mankin; Carol A Trahan; Gertrud Fondren; Carole J Mankin
Journal:  Chir Organi Mov       Date:  2009-04-29

Review 5.  Efficacy of minimally invasive techniques for enhancement of fracture healing: evidence today.

Authors:  Ippokratis Pountos; Theodora Georgouli; George Kontakis; Peter V Giannoudis
Journal:  Int Orthop       Date:  2010-02       Impact factor: 3.075
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.